Sonoma Pharmaceuticals, Inc.

SNOA

Sonoma Pharmaceuticals, Inc.

SNOA

Insider Sentiment (TTM):

Last Purchase:2018-03-13Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:67,346Shares Outstanding:1,684,000Institutional Ownership Pct.:4.00%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	5	2	3	3	4	5	5	4	3	3	2	2
Accounts Receivable Net Current	3	3	2	3	3	2	2	3	3	3	3	2
Inventory Net	4	4	4	4	4	3	3	3	3	3	3	3
Prepaid Expense And Other Assets Current	4	3	3	3	3	2	1	2	3	4	4	4
Assets Current	16	12	12	13	13	13	12	12	12	13	13	12
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	1	0	1	0	0	0	0	0	0	0
Deferred Income Tax Assets Net	1	1	0	1	1	1	1	1	1	1	1	1
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	18	14	14	14	15	14	14	14	14	15	15	14
Liabilities Current
Accounts Payable Current	2	2	2	1	2	1	1	1	1	1	1	1
Accounts Payable And Other Accrued Liabilities	3	2	2	2	2	2	2	2	2	2	2	2
Deferred Revenue Current	0	0	0	1	1	1	0	0	0	0	0	0
Other Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	0	0
Short Term Borrowings	0	0	0	0	0	0	0	0	0	0	-	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	5	5	4	4	5	4	4	3	4	4	3	3
Deferred Revenue Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Liability Noncurrent	0	0	1	0	0	0	0	0	0	0	0	0
Liabilities	12	11	10	10	11	9	9	8	9	9	8	8
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	211	207	207	207	207	207	206	206	204	203	203	201
Retained Earnings Accumulated Deficit	-201	-201	-200	-200	-199	-198	-197	-196	-195	-194	-193	-192
Accumulated Other Comprehensive Income Loss Net Of…	-3	-3	-3	-3	-4	-4	-5	-4	-4	-3	-3	-3
Stockholders Equity	7	3	3	4	4	4	5	5	5	6	7	6
Liabilities And Stockholders Equity	18	14	14	14	15	14	14	14	14	15	15	14
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	-	-	0	-	-
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	-	-	1	-	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	-	-	0	-	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	-	-	0	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	50	50	50	50	50	50	50	50	24	24	24	24
Common Stock Shares Issued	5	2	2	2	2	2	2	1	1	1	1	13
Shares Outstanding	5	2	2	2	2	2	2	1	1	1	1	13

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2027	-	-	-	-	-	-	-	-	-	-	-	-
2026	43.09%	29.90%	24.12%	-11.44%	-3.99%	-8.78%	-15.30%	-15.66%	-57.30%	14.55%	-	-
2025	-46.77%	-48.23%	-51.77%	-4.45%	-5.82%	-2.74%	-14.66%	-9.40%	59.02%	22.37%	3.73%	60.34%
2024	-8.00%	-23.00%	-82.00%	12.50%	12.50%	0.00%	0.00%	6.25%	0.00%	117.65%	47.06%	-3.53%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.99	2.50	2.88	2.89	2.70	3.09	3.34	3.69	3.18	3.37	4.07	3.56
Quick Ratio	1.56	1.04	1.21	1.37	1.33	1.91	2.12	2.25	1.62	1.69	1.80	1.42
Working Capital	10.82M	7.27M	7.93M	8.18M	8.26M	8.55M	8.68M	8.91M	8.18M	8.83M	9.43M	8.28M
Leverage & Debt
Debt to Equity	1.75	3.51	2.97	2.66	2.60	2.10	1.81	1.56	1.75	1.40	1.18	1.40
Interest Coverage TTM	-	-	-	-	-	-	-	-	-	-	-370.17	-417.85
Debt Ratio	0.64	0.78	0.75	0.73	0.72	0.68	0.64	0.61	0.64	0.58	0.54	0.58
Efficiency & Turnover
Asset Turnover TTM	1.34	1.41	1.30	1.23	1.06	1.01	0.99	0.99	0.86	0.82	0.86	0.85
Days Sales Outstanding TTM	48.16	44.47	49.30	63.14	71.58	65.53	68.97	72.48	81.71	78.39	76.69	70.95
Receivables Turnover TTM	7.58	8.21	7.40	5.78	5.10	5.57	5.29	5.04	4.47	4.66	4.76	5.14
Per Share Metrics
Diluted EPS TTM	-0.59	-1.89	-1.97	-2.11	-2.17	-2.79	-2.56	-3.56	-5.36	-10.63	-9.30	-23.83
Free Cash Flow Per Share TTM	-1.24	-2.08	-1.81	-1.04	0.84	-0.14	0.07	-1.51	-3.67	-5.35	-9.53	-17.34
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	38.91%	37.97%	38.16%	37.68%	37.71%	38.25%	35.98%	38.52%	38.17%	37.26%	33.45%	28.80%
Operating Profit Margin TTM	-6.41%	-12.60%	-15.61%	-18.42%	-24.36%	-25.97%	-31.94%	-31.56%	-36.49%	-36.91%	-36.08%	-44.83%
Net Profit Margin TTM	-10.33%	-16.26%	-19.02%	-20.54%	-23.84%	-24.20%	-26.82%	-27.21%	-35.91%	-37.97%	-41.23%	-50.75%
Growth Metrics
Net Revenue Growth (1Y)	47.00%	36.68%	26.83%	25.02%	17.43%	12.19%	13.51%	11.81%	-0.13%	-4.05%	-1.96%	-3.18%
Net Income Growth (1Y)	-36.32%	-8.16%	-10.09%	-5.62%	-22.04%	-28.50%	-26.16%	-40.06%	-19.75%	-6.13%	-25.21%	6.16%
EPS Growth (1Y)	-72.83%	-32.32%	-23.16%	-40.71%	-59.57%	-73.79%	-72.46%	-85.04%	-76.73%	-64.99%	-78.72%	3,090.05%
Valuation Metrics
P/E TTM	-2.09	-1.13	-1.85	-1.84	-1.32	-0.79	-1.05	-0.86	-0.78	-0.32	-0.39	-0.65
P/B TTM	0.72	1.16	1.82	1.69	1.15	0.62	0.81	0.59	0.72	0.25	0.29	0.70
P/S TTM	0.22	0.18	0.35	0.38	0.31	0.19	0.28	0.23	0.28	0.12	0.16	0.33
Market Cap	4.73M	3.59M	6.24M	6.39M	4.68M	2.72M	3.94M	3.17M	3.57M	1.55M	1.97M	3.97M
Enterprise Value	-467.42K	1.41M	3.67M	3.41M	1.21M	-2.44M	-1.30M	-821.62K	1.19M	-1.26M	-440.40K	1.84M
Calculated Values
Free Cash Flow TTM	-4.78M	-3.50M	-3.09M	-1.72M	1.37M	-168.00K	108.00K	-1.56M	-3.12M	-2.44M	-5.20M	-4.48M
Net Debt	-5.20M	-2.18M	-2.56M	-2.98M	-3.47M	-5.15M	-5.24M	-4.00M	-2.39M	-2.81M	-2.41M	-2.14M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2018-03-13Purchase

Owner: Miller, Robert E

Title: Chief Financial Officer

Shares: 1,200

Price/Share: $4.10

Value: $4,920.00

Shares Owned: 18,868

Relationship: Officer

Ownership: Indirect

2018-03-09Purchase

Owner: Miller, Robert E

Title: Chief Financial Officer

Shares: 1,200

Price/Share: $3.90

Value: $4,680.00

Shares Owned: 15,268

Relationship: Officer

Ownership: Indirect

2018-03-08Purchase

Owner: Schutz, James J

Title: Chief Executive Officer

Shares: 2,473

Price/Share: $3.99

Value: $9,867.27

Shares Owned: 35,858

Relationship: Director,Officer

Ownership: Direct

2017-11-30Purchase

Owner: Schutz, James J

Title: Chief Executive Officer

Shares: 345

Price/Share: $4.95

Value: $1,707.75

Shares Owned: 16,174

Relationship: Director,Officer

Ownership: Direct

2017-11-29Purchase

Owner: Miller, Robert E

Title: Chief Financial Officer

Shares: 1,790

Price/Share: $5.03

Value: $9,003.70

Shares Owned: 14,068

Relationship: Officer

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2018-03-13	Miller, Robert E	Officer	Chief Financial Officer	Indirect	Purchase	1,200	4.10	$4,920.00	18,868	4
2018-03-09	Miller, Robert E	Officer	Chief Financial Officer	Indirect	Purchase	1,200	3.90	$4,680.00	15,268	4
2018-03-08	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	2,473	3.99	$9,867.27	35,858	4
2017-11-30	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	345	4.95	$1,707.75	16,174	4
2017-11-29	Miller, Robert E	Officer	Chief Financial Officer	Indirect	Purchase	1,790	5.03	$9,003.70	14,068	4
2017-11-29	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	400	5.03	$2,012.00	15,829	4
2017-11-24	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	254	5.05	$1,282.70	15,429	4
2017-11-21	Miller, Robert E	Officer	Chief Financial Officer	Indirect	Purchase	2,000	5.04	$10,080.00	12,278	4
2017-08-10	Miller, Robert E	Officer	Chief Financial Officer	Indirect	Purchase	2,264	5.30	$11,999.20	10,728	4
2017-08-10	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	929	5.46	$5,072.34	15,175	4
2017-08-10	Umscheid, Marc	Officer	Chief Strategy/Mkt Officer	Direct	Purchase	600	5.31	$3,186.00	3,392	4
2017-03-09	Miller, Robert E	Officer	Chief Financial Officer	Indirect	Purchase	750	7.02	$5,265.00	8,464	4
2017-03-08	Miller, Robert E	Officer	Chief Financial Officer	Indirect	Purchase	1,000	6.89	$6,890.00	7,714	4
2017-03-06	Umscheid, Marc	Officer	Chief Strategy/Mkt Officer	Direct	Purchase	750	6.82	$5,115.00	750	4
2017-03-03	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	800	6.76	$5,408.00	11,840	4
2016-12-08	Miller, Robert E	Officer	Chief Financial Officer	Indirect	Purchase	5,000	4.86	$24,300.00	6,714	4
2016-12-08	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	1,000	4.88	$4,880.00	11,040	4
2016-08-15	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	1,328	3.66	$4,860.48	6,505	4
2016-02-25	Schutz, James J	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	1.00	$5,000.00	25,885	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

4.00%

Inst. Shares: 67,346

Shares Outstanding: 1,684,000

2025-12-31

6.36%

Inst. Shares: 108,913

Shares Outstanding: 1,713,000

2025-09-30

3.61%

Inst. Shares: 59,357

Shares Outstanding: 1,646,000

2025-06-30

5.17%

Inst. Shares: 84,901

Shares Outstanding: 1,641,000

2025-03-31

1.71%

Inst. Shares: 21,224

Shares Outstanding: 1,241,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	67,346	1,684,000	4.00%
2025-12-31	108,913	1,713,000	6.36%
2025-09-30	59,357	1,646,000	3.61%
2025-06-30	84,901	1,641,000	5.17%
2025-03-31	21,224	1,241,000	1.71%
2024-12-31	20,159	1,464,000	1.38%
2024-09-30	27,765	1,034,000	2.69%
2024-06-30	413,495	851,000	48.59%
2024-03-31	164,265	455,000	36.10%
2023-12-31	275,942	546,000	50.54%
2023-09-30	111,822	258,000	43.34%
2023-06-30	125,044	246,800	50.67%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Sonoma Pharmaceuticals, Inc. (SNOA) — SEC Financial Statements & Analysis

Sonoma Pharmaceuticals, Inc. (SNOA) is a surgical & medical instruments & apparatus company, incorporated in DE. Sonoma Pharmaceuticals, Inc. trades on Nasdaq as: SNOA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Sonoma Pharmaceuticals, Inc. reported a 47.00% year-over-year revenue growth, a Gross Profit Margin of 38.91% (TTM), a Debt-to-Equity ratio of 1.75x, a Price-to-Sales (P/S) ratio of 0.22x (TTM), a Price-to-Book (P/B) ratio of 0.72x (TTM), at a market cap of $4.73M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 47.00%
Gross Profit Margin TTM: 38.91%
Debt To Equity: 1.75x
P/S TTM: 0.22x
P/B TTM: 0.72x
Market Cap: $4.73M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Sonoma Pharmaceuticals, Inc. in?

Sonoma Pharmaceuticals, Inc. (SNOA) operates in the Surgical & Medical Instruments & Apparatus industry.

What is SNOA's market cap?

Sonoma Pharmaceuticals, Inc. (SNOA) has a market capitalization of $4.73M as of 2026-06-30.

What exchange does SNOA trade on?

Sonoma Pharmaceuticals, Inc. (SNOA) trades on the Nasdaq.

Where is Sonoma Pharmaceuticals, Inc. incorporated?

Sonoma Pharmaceuticals, Inc. is incorporated in DE.